(600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 600488 · · 13 pages · Chinese
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Earlier from Tianjin Tianyao Pharmaceuticals
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Notice on Convening the 3rd Extraordinary General Meeting in 2026
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Amendment to the Articles of Association and Filing of Industrial and Commercial Registration Changes
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Obtaining Drug Registration Certificate for Nicardipine Hydrochloride Injection by Subsidiary
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading
Later from Tianjin Tianyao Pharmaceuticals
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Receipt of the Approval Notice for the Marketing Application of a Chemical API
- (600488)"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Outline of the Q3 2026 Performance Briefing
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals